Table 2

Comparison of WMH distribution on the modified Schelten’s scale between NOTCH3 variant carriers and non-carriers

Brain regionsNumber (%) of non-carrier casesNumber (%) of mutation casesOR (95% CI)P value
Periventricular white matter108 (73)36 (80)1.51 (0.65 to 3.88)0.34
Frontal white matter119 (80)40 (89)1.40 (0.50 to 4.57)0.53
Parietal white matter79 (53)34 (76)2.44 (1.11 to 5.68)0.03
Occipital white matter45 (30)20 (44)1.82 (0.88 to 3.80)0.11
Anterior temporal white matter12 (9)17 (38)7.65 (3.14 to 19.81)<0.001
Posterior temporal white matter45 (30)14 (31)0.94 (0.42 to 2.03)0.87
Corpus callosum7 (5)5 (11)2.34 (0.65 to 7.95)0.18
Caudate1 (1)3 (7)7.80 (1.30 to 72.60)0.03
Putamen16 (11)9 (20)1.97 (0.77 to 4.88)0.15
Globus pallidus4 (3)0 (0)0.19 (0.00 to 2.13)0.21
Thalamus4 (3)6 (13)3.90 (1.05 to 14.91)0.04
Internal capsule3 (2)2 (4)2.20 (0.35 to 11.12)0.37
External capsule9 (6)17 (38)13.32 (4.96 to 39.89)<0.001
Cerebellum4 (3)3 (7)2.10 (0.43 to 8.91)0.34
Mesencephalon3 (2)2 (4)3.84 (0.57 to 27.84)0.16
Pons25 (17)11 (24)1.51 (0.64 to 3.46)0.34
Medulla2 (1)0 (0)0.80 (0.01 to 8.86)0.87
  • Table showing the effect of the presence of NOTCH3 variants on the odds of developing any WMH in each brain region.

  • WMH, white matter hyperintensity.